Premier Integrated Labs has entered into a strategic partnership with global medical technology leader Mindray through the signing of a Memorandum of Understanding (MoU). This collaboration aims to advance in-vitro diagnostics (IVD) innovation, enhance healthcare delivery, and bring cutting-edge diagnostic solutions to medical institutions and patients across Malaysia.
Premier Integrated Labs, in partnership with Lifespin GmbH, introduces Malaysia’s first Metabolomic Testing—an AI-powered test analyzing 250+ biomarkers for early disease detection and personalized health insights.
Premier Integrated Labs has launched a state-of-the-art laboratory in Kuching, strengthening diagnostic services in Sarawak. Officiated by Deputy Health Minister YB Dato Lukanisman Awang Sauni, the expansion enhances early disease detection and supports the region’s growth as a medical tourism hub.
Premier Integrated Labs welcomed partners and vendors to its new Corporate Office, fostering collaboration and shared growth. The event was followed by PIL Townhall 2025, where CEO En Hareeff shared key updates, celebrated achievements, and aligned the team on the company’s vision. It was a day of connection, inspiration, and renewed commitment to success.
Premier Integrated Labs (PIL), in collaboration with Roche, successfully hosted a symposium at The Vertical, Bangsar South, on 8th December 2024. With over 50 attendees, including healthcare professionals and organizations, the event highlighted the importance of HPV primary screening in cervical cancer elimination.
Premier Integrated Labs (PIL) and Taylor’s University have partnered to provide hands-on training for students, advance biomedical research, and integrate industry insights into education, bridging academia and industry for future healthcare advancements.
Premier Integrated Labs and Axon Alpha Specialist Centre have partnered to enhance diagnostic services and patient care. Through this collaboration, we aim to provide seamless, accurate, and efficient laboratory support, improving clinical decisions and healthcare outcomes.
Premier Integrated Labs, Genomax Technologies, and Veracyte have partnered to enhance breast cancer care in Malaysia with the Prosigna® Breast Cancer Assay (PAM50), enabling more precise and personalized treatment.
